Stephen Tindal is director, Formulation and Site R&D Lead at Catalent Pharma Solutions.
Bridging the Gap from Molecule to Drug
Formulation expertise can smooth the transition of a prospective therapy from medicinal chemistry to drug dosage form.
Opportunities with Softgels
Stephen Tindal from Catalent Pharma Solutions speaks with Pharmaceutical Technology Europe about advances in softgel technologies.